TA
CLVS

Teachers Advisors’s Clovis Oncology, Inc. CLVS Stock Holding History

Teachers Advisors’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$2.53M Buy
102,113
+3,305
+3% +$82.9K ﹤0.01% 1842
2018
Q4 		$1.77M Sell
98,808
-45,753
-32% -$935K ﹤0.01% 1914
2018
Q3 		$4.25M Buy
144,561
+1,278
+0.9% +$49.5K 0.01% 1546
2018
Q2 		$6.51M Buy
143,283
+8,075
+6% +$393K 0.01% 1275
2018
Q1 		$7.14M Sell
135,208
-216,460
-62% -$12.6M 0.01% 1160
2017
Q4 		$23.9M Sell
351,668
-127,709
-27% -$8.93M 0.03% 628
2017
Q3 		$39.5M Buy
479,377
+9,805
+2% +$777K 0.05% 392
2017
Q2 		$44M Sell
469,572
-21,522
-4% -$1.32M 0.06% 368
2017
Q1 		$31.3M Buy
491,094
+70,582
+17% +$4.29M 0.05% 457
2016
Q4 		$18.7M Buy
420,512
+254,898
+154% +$8.97M 0.03% 663
2016
Q3 		$5.97M Buy
165,614
+114,900
+227% +$2.47M 0.01% 1142
2016
Q2 		$696K Buy
50,714
+8,308
+20% +$121K ﹤0.01% 2241
2016
Q1 		$814K Buy
42,406
+1,436
+4% +$30.4K ﹤0.01% 2080
2015
Q4 		$1.43M Sell
40,970
-61,032
-60% -$3.94M ﹤0.01% 1793
2015
Q3 		$9.38M Buy
102,002
+4,631
+5% +$401K 0.02% 881
2015
Q2 		$8.56M Buy
97,371
+61,941
+175% +$5.3M 0.02% 961
2015
Q1 		$2.63M Buy
35,430
+646
+2% +$45.6K ﹤0.01% 1474
2014
Q4 		$1.95M Buy
34,784
+75
+0.2% +$3.94K ﹤0.01% 1657
2014
Q3 		$1.57M Sell
34,709
-34
-0.1% -$1.42K ﹤0.01% 1754
2014
Q2 		$1.44M Sell
34,743
-89,655
-72% -$4.62M ﹤0.01% 1846
2014
Q1 		$8.62M Buy
124,398
+32,550
+35% +$2.39M 0.02% 884
2013
Q4 		$5.54M Buy
91,848
+70,610
+332% +$3.84M 0.01% 1042
2013
Q3 		$1.29M Buy
21,238
+2,682
+14% +$190K ﹤0.01% 1765
2013
Q2 		$1.24M Buy
+18,556
New +$834K ﹤0.01% 1718

Other funds holding CLVS

PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Teachers Advisors's CLVS Position: Q1 2019 in Review

Teachers Advisors increased its Clovis Oncology, Inc. (CLVS) stake by 3.3% in Q1 2019, buying an estimated $82.9K and bringing the position to 102,113 shares worth $2.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1842.

Teachers Advisors first reported a position in CLVS in Q2 2013 and has held it in 24 quarters since. The position peaked at $44M in Q2 2017. 186 funds tracked by Wall St. Rank hold CLVS as of Q1 2019.

  • Teachers Advisors held 102,113 shares of Clovis Oncology, Inc. worth $2.53M as of Q1 2019.
  • Teachers Advisors bought 3,305 Clovis Oncology, Inc. shares in Q1 2019, an estimated $82.9K.
  • Clovis Oncology, Inc. made up ﹤0.01% of Teachers Advisors's portfolio in Q1 2019, its #1842 holding.
  • Teachers Advisors first reported a position in Clovis Oncology, Inc. in Q2 2013 and has held it in 24 quarters since.
  • Teachers Advisors's Clovis Oncology, Inc. position peaked at $44M in Q2 2017.
  • 186 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2019.

Based on Teachers Advisors's 13F filing for Q1 2019, filed 14 May 2019.